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Abstract
In this study, we propose a hidden Markov mixture model for the analysis of gene expression measure-
ments mapped to chromosome locations. These expression values represent preprocessed light intensities
observed in each probe of Affymetrix oligonucleotide arrays. Here, the algorithm BLAT is used to align
thousands of probe sequences to each chromosome. The main goal is to identify genome regions as-
sociated with high expression values which define clusters composed by consecutive observations. The
proposed model assumes a mixture distribution in which one of the components (the one with the highest
expected value) is supposed to accommodate the overexpressed clusters. The model takes advantage of
the serial structure of the data and uses the distance information between neighbours to infer about the
existence of a Markov dependence. This dependence is crucially important in the detection of overex-
pressed regions. We propose and discuss a Markov chain Monte Carlo algorithm to fit the model. Finally,
the proposed methodology is used to analyse five data sets representing three types of cancer (breast,
ovarian and brain).
keywords: gene expression; microarray; Affymetrix; cancer; Gibbs sampling.
1 Introduction
DNA microarray platforms have been widely used in the past years to simultaneously measure the expression
levels of a large number of genes; see Amaratunga et al. (2014) for a comprehensive coverage of recent
advances in microarray data analysis. In particular, the high density Affymetrix GeneChip oligonucleotide
array technology (Dalma-Weiszhausz et al., 2006) is the most popular platform used in biomedical researches
focused on expression profiling and DNA analysis, at a genome global level or based on a subset of genes.
Irizarry et al. (2003), Carvalho and Irizarry (2010), Mayrink and Lucas (2013), Li et al. (2013) and Mayrink
and Lucas (2015) are few examples of works dealing with this type of data.
In the present study, we are concerned with the identification of chromosome regions associated with
high expression measurements obtained from the aforementioned Affymetrix microarrays. In order to link
each expression value to a location in the chromosome, we consider the sequence alignment algorithm BLAT
(Kent, 2002) designed to map millions of sequence reads against the human genome. The main advantage
of this algorithm when compared to others is its considerably faster performance, which allows for a more
regular update of the genome. We provide further details about BLAT in Appendix A.
The identification of differentially expressed probe sets has been the topic of some recent works. In
particular, Warren et al. (2007) proposed a method to generate detection calls “present”, “marginal” and
“absent” indicating the activity status of genes in the samples. In brief, the authors identify Affymetrix
probe sets which cannot hybridize to the intended transcript, and use the empirical cumulative distribution
of their intensities to derive a cutoff intensity. A probe set is thus classified as “Present” if its expression
value is higher than the established threshold. The main critique to this method is the arbitrary choice of
the cutoff point, which directly affects the classification of probe sets with intensities close to the unknown
border separating the high and low categories.
In the present work, we are interested in the identification of overexpressed chromosome regions, based
on the BLAT probe expression mapping. In particular, we analyse data from three types of cancer – breast,
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ovarian and brain. We consider three data sets from the first type and one data set from each of the other
two types. An overexpressed status suggests that a gene plays an important role in the progression of the
tumor being investigated; the region identification provided in our study calls the attention for specific parts
of the genome where one can find several genes (not only those from the arrays) potentially having a key
contribution for understanding the disease.
In order to avoid choosing an arbitrary threshold to classify a value as overexpressed, we take advantage
of the irregularly spaced serial structure of the data by using the neighbourhood and distance information.
More specifically, we propose a semiparametric hidden Markov model to fit the observations using a mixture
distribution with some gammas and a single Gaussian components. The latter is supposed to accommodate
the overexpressed clusters. The gamma components are inserted to deal with the skewness and multimodality
exhibited by the data. Finally, we consider a mixture of discrete distributions to model the uncertainty on
the Markov dependence.
We develop a Markov chain Monte Carlo (MCMC) algorithm to perform inference under the Bayesian
paradigm. The algorithm is a Gibbs sampling designed to have good convergence properties. This is achieved
by a careful choice of the blocking and update schemes. The most crucial step of the algorithm involves a
backward-filtering-forward-sampling strategy.
Mixture models for microarray data have been explored in several previous works. For example, Lewin
et al. (2007) present a Bayesian hierarchical model to determine the expression status of genes using a
mixture prior distribution for the parameters representing differential effects. Broet et al. (2002) consider a
mixture of Gaussians at the data level of the model hierarchy to identify expression changes. A Gaussian
mixture is also used in Do et al. (2005) for the analysis of differentially expressed genes between normal and
colon cancer tissue samples. Some other examples are: Efron et al. (2001), Newton et al. (2001), Parmigiani
et al. (2002), Broet et al. (2004) and Dean and Raftery (2005). None of these works, however, consider the
information regarding the position of the expressions along the chromosomes.
In computational biology, one can easily find studies evaluating data sets containing genome map position
information (see Yi et al., 2005; Xu et al., 2013; Cheung et al., 2005; Lucas et al., 2010). In the context of
copy number data, Pollack et al. (2002) explores genome-wide measurements of DNA copy number alteration
by array CGH; their data are log2-base fluorescence ratios images depicting amplifications, deletions and
unchanged values across the chromosomes. Broet and Richardson (2006) propose a novel method called
CGHmix to investigate copy number changes, based on a spatially structured mixture model. Other few
examples accounting for the spatial dependency along the chromosomes are: Autio et al. (2003), Jong
et al. (2004) and Picard et al. (2005). Another common research topic using chromosome location data is
the study or comparison of genome alignment tools; for example, Allen et al. (2011) review and compare
different approaches to map probes across different microarray platforms.
There is an extensive literature dedicated to methodologies to deal with irregularly spaced serial data.
In a continuous-time context, discretely observed diffusion processes might be one option (see Beskos et al.,
2006). Many studies, including the present paper, assume a discrete-time configuration which can be ap-
propriately explored through a particular case of a more general geostatistical model with neighbourhood
weights decaying with distance; see, for example, dynamic and state-space models investigated in Shephard
(1994), Fruhwirth-Schnatter (1994) and Gelfand et al. (2005).
One-dimensional change point models may be considered to address the clustering problem accounting for
the serial structure of the data. These methods were developed to identify parameter shifts in a distribution
assumed for the sequential data. An interesting approach is the Product Partition Model (PPM) introduced
by Hartigan (1990) and Barry and Hartigan (1992); its spatial version, presented in Page and Quintana
(2015), uses the Euclidean distances between neighbours to determine the probability of the partitions.
However, the model fit would be burdensome to handle thousands of chromosome locations; the PPM
generates the unknown change points and this may not be a practical task. As an alternative, Chib (1998)
proposed a model assuming a fixed number of regimes and treating the breaking process as a Markov chain
with transition probabilities constrained so that regimes come in a non-reversible sequence. The author
indicates that the transition probabilities can be a function of covariates (e.g. the distance information);
however, the Markov dependence is assumed true across the whole series despite the distance between
neighbours.
The outline of this paper is as follows: in Section 2, we present all aspects considered to obtain the final
data set for analysis; they include: short description of the microarray structure and a scale transformation
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to better manage the distances between observations. In Section 3, we propose a hidden Markov mixture
model to identify overexpressed regions of the chromosomes. Section 4 presents and details the Bayesian
inference procedure, including an MCMC algorithm and an strategy to perform the cluster detection based
on the output of this algorithm. Section 5 presents the analysis of five data sets representing three types of
cancer. Finally, in Section 6, we summarise and discuss the main conclusions of the study.
2 The data
We consider Affymetrix HG-U133A oligonucleotide arrays previously explored in Miller et al. (2005), Wang
et al. (2005), Sotiriou et al. (2006), Marks et al. (1991) and Freije et al. (2004). The first three studies
are related to breast cancer; the last two refer to ovarian and brain cancer, respectively. Hereafter, we will
denote these data sets by “Breast 1” (251 samples), “Breast 2” (286 samples), “Breast 3” (189 samples),
“Ovarian” (141 samples) and “Brain” (59 samples); these arrays contain expressions of thousands of genes.
In brief, an Affymetrix GeneChip consists of a quartz wafer (chip) to which are attached approximately
500,000 different known 25-mer oligonucleotides. The data is obtained through an hybridization procedure
where: mRNA are extracted from the cells or tissues of interest, labeled with fluorescent tags and combined
with the chip. The mRNA single strands are expected to connect to its complementary sequences, if found,
in a specific spot within the array. These array spots are called “probes” and they represent a fraction of
a gene. Each transcript is represented on an array by a series of 11-20 probe pairs known as a probe set;
for simplicity, we may refer to a probe set as a gene. Each pair consists of a perfect match probe (PM),
with its 25-base sequence identical to the gene of interest, and a mismatch probe (MM), whose sequence
is the same as the PM except for the 13th position, where the base is set to the PM complementary. The
MM probe was introduced by Affymetrix as a measure of non-specific binding or cross-hybridization. After
the hybridization, the array is washed to remove unconnected material and a laser is applied to activate
the fluorescence. Finally, a scanner is used to measure a positive and continuous value of light intensity
representing the expression signature in each probe.
In the proposed application, these expression data are mapped to chromosome locations through the
alignment tool BLAT – see Appendix A. Another step to be considered for the raw Affymetrix expression
data is a preprocessing routine to remove part of the systematic noise effect aggregated during the experiment
to build the arrays. We consider the most popular method known as Robust Multi-chip Average (RMA)
(see Irizarry et al., 2003), also described in Appendix A.
(a) (b)
Figure 1: Graphs related to the data set “Breast 1”. Panel (a): Histogram displaying the distribution of the medians of the
preprocessed log2-base intensities identified via BLAT in all chromosomes (1-22, X, Y). Panel (b): points showing the positions of the
medians along chromosome 4.
Figure 1 presents a histogram in panel (a) indicating a skewed and multimodal distribution for the
expression data (Breast 1) mapped to the chromosomes. Panel (b) shows the spatial configuration of the
data along the chromosome 4 with distances varying between data points. Here, we consider the original
scale of chromosome positions identified via BLAT; the minimum, average and maximum distances are: 1,
53,300 and 3,160,573, respectively. The total number of probes mapped to chromosome 4 is 3,582. Other
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chromosomes in the human genome have similar results, but their lengths differ; in particular, Y is the
shortest one.
The analysis of Figure 1 (b) motivates the use of a hypothesis test to verify the spatial dependence in the
data. A well known test for this purpose is based on the Moran’s I statistics (Moran, 1950). We consider
the R package spdep (Bivand and Piras, 2015) to apply a Monte Carlo version of this test. In brief, the
Moran’s I, with weights based on the inverse distance between locations, is calculated for the observed data
and for many random permutations of the expression values. The resulting p-value represents how often the
observed Moran’s I is close to those obtained for the permuted data with no spatial association.
(a) (b)
Figure 2: Panel (a): Image displaying all p-values of the Moran’s I permutation test applied to the data set “Breast 1”; each row
represents a microarray and each column represents a chromosome (1-22, X and Y). Panel (b): Histogram of all rescaled distances
between locations in all chromosomes.
Figure 2 (a) shows a heat map graph representing the magnitude of the Moran’s I permutation test
p-values for each chromosome and each microarray of the “Breast 1” data; similar results were obtained
for the other data sets. Note that all p-values are small (< 0.05) suggesting that the spatial association
is significant. In particular, chromosome 15 concentrates the largest p-values, but none of them are high
enough to reject the association. In summary, these tests indicate presence of spatial dependence in the
aligned data and thus motivate a model taking into account the distances between neighbours.
Note that the original BLAT distances are too large and might lead to computational difficulties to fit a
model. In order to avoid this issue, we rescale those distances to the interval (0,1) using two steps: calculate
the log-distances and divide each of them by the maximum log-distance. The model proposed in the next
section will assume the distances as covariates, therefore, other transformations can be considered and this
might affect the inference, but it does not change the structure of our model. Taking the logarithm will
preserve high differences among the smallest values and practically even out the highest values. This is
coherent with the model we propose to perform the analysis, as it will be discussed in the next section.
Figure 2 (b) shows a histogram for all rescaled distances in the chromosomes.
3 Hidden Markov mixture model
Let n be the number of locations to be analysed and L the number of arrays. Define X = {Xi, i = 1, . . . , n},
Y = {Yi, i = 1, . . . , n} and Yi = {Yil, l = 1, . . . , L}, where Xi is the true expression (latent) of location i
and Yil is the preprocessed expression of location i observed with noise (w.r.t. Xi) in array l.
Since the distribution of each Yi is unimodal, fairly symmetric and L is large (59-286 in our applications),
we assume Xi = Y˜i, for simplicity, where Y˜i is the median of Yi. Nevertheless, the variability of the
replications could be modeled by assuming, for example, Yil ∼ N(Xi, τ2i ).
The main goal of this analysis is to detect overexpressed regions in each chromosome. The naive attempt
of fixing an arbitrary threshold value and looking at the probes with expression intensity higher than this
value is discarded for several reasons. Firstly, there is no explicit gap in the distribution of the expression
intensity values in each chromosome. Secondly, there is no clear scale of the measured intensity, due to all
the preprocessing of the data. Finally, this attempt would not take into account the dependence known to
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exist among near probes. It is natural to assume that near probes, in the chromosome sequence, are likely to
have similar expression intensities. As an example, see the identification of chromosomal regions with DNA
copy number alteration in Pollack et al. (2002) and Lucas et al. (2010).
Our approach considers an stochastic model that uses the dependence among near probes to detect the
overexpressed regions. More specifically, the regions of interest are linked to the component of highest mean
in a mixture distribution. This way, no fixed threshold needs to be provided. The dependency information
is used in a way that near probes are likely to be in the same component of the mixture. Generally speaking,
the overexpressed regions are detected as sequences of probes that have the highest expression intensities in
the chromosome. The dependence structure disfavors the detection of spikes, i.e. an isolated probe and none
of its neighbours being detected as overexpressed. Finally, informative prior distributions for the parameters
of the proposed model are crucial to achieve the desired goal.
The multimodality in Figure 1 (a) motivates the use of a mixture distribution to model the expressions
X. This approach also allows the definition of the overexpressed regions, in a stochastic way, by associating
them to one of the components in the mixture. This is the component with the highest mean and it is
assumed to be a normal distribution. The remaining components of the mixture are assumed to be gamma
distributions, which is motivated by the positive, multimodal and skewed features of the data in Figure 1 (a)
(see Wiper et al., 2001). One might consider here a mixture of normal distributions instead; however, this
would require a larger number of components to fit the data (see Baudry et al., 2010). Mixtures of gammas
have been explored in different contexts (see, for example, Dey et al., 1995; Nascimento et al., 2012).
Given that BLAT maps thousands of probe expressions to each chromosome and that the majority
of locations have neighbours relatively close, it is unlikely that a single location with an intensity much
higher than its neighbours is in fact an observation within an overexpressed region. In other words, the
neighbourhood structure is crucial in the detection of such regions. This spiked configuration suggests a
local atypical expression and is expected to be modelled (associated) to the right tail of a gamma component
in the mixture. The local outlier may be explained by cross-hybridization, incorrect probe mapping and
other aspects involving the microarray assembling and the alignment tool. The cases where an isolated
high expression probe may belong to a potential overexpressed region are those where its nearest observed
neighbours are too far away.
We use a Markov structure to model the dependence among probes. However, given the irregular structure
of distances between locations in the data, a discrete time Markov chain on (a discretised version of) the
distance scale would be both algebraically and computationally expensive. Therefore, we define a Markov
structure on the ordering of the probes, i.e. the Markov dependence (if existent) is the same for any
consecutive pair of probes. However, such dependence is assumed to be uncertain, i.e. to exist with some
probability. In a lower level of the model, we use the distance information to model this probability.
Let K be the number of gamma components in the mixture. This means that the full mixture has K + 1
components where the one with the largest mean is normal. Define q0 = (q01, . . . , q0(K+1))
′ as a probability
vector and Q = {qk1k2}, k1, k2 = 1, . . . ,K + 1, as a transition matrix of a K + 1 states and discrete time
Markov chain. Let also qk, k = 1, . . . ,K + 1, be the k-th row of Q. Let Fk be the c.d.f. of a gamma
distribution with mean θk and shape parameter ηk, for k = 1, . . . ,K, and FK+1 is the c.d.f. of a normal
distribution with mean µ and variance σ2. Denote fk as the density implied by Fk, k = 1, . . . ,K + 1.
Define the vector Zi = (Zi,1, . . . , Zi,K+1)
′ such that Zi,k = 1 indicates that Xi belongs to the k-th mixture
component, 0 otherwise. We propose the following model:
(Xi|Zi,k = 1) ∼ Fk, i = 1, . . . , n, all independent; (1)
(Z1|q0) ∼ Mult(1, q0); (2)
(Zi|Zi−1,k = 1, ρi, q0, Q) ∼ (1− ρi) Mult(1, q0) + ρi Mult(1, qk), i = 2, . . . , n, (3)
where Mult refers to the multinomial distribution and the parameters indexing the mixture components are
supressed from the conditional notation. The distribution in (3) states that a Markov dependence between
the expressions in the locations i− 1 and i is present with probability ρi.
The model in (1)-(3) is not an ordinary mixture model because the Xi variables are not marginally (w.r.t.
Z) independent. Their dependence, however, is defined in a second (and latent) level of the model through
a Markov structure. This fact qualifies our model as a Hidden Markov Model (HMM). For modelling and
computational reasons, we define Bernoulli random variables Wi, i = 2, . . . , n, that indicate the presence of
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the Markov dependence. That is,
(Zi|Zi−1,k = 1,Wi = 0, q0) ∼ Mult(1, q0), i = 2, . . . , n; (4)
(Zi|Zi−1,k = 1,Wi = 1, Q) ∼ Mult(1, qk), i = 2, . . . , n; (5)
(Wi|ρi) ∼ Ber(ρi), i = 2, . . . , n. (6)
For notation reasons, define W1 = 0 almost surely and (Z1|Z0,W1 = 0, q0) := (Z1|q0).
Our Bayesian model is fully specified by adopting appropriate prior distributions. Let Φ be the c.d.f. of
the standard normal distribution and define di as the (transformed) distance between locations i− 1 and i.
We adopt the following prior specifications:
q0 ∼ Dir(r0);
qk ∼ Dir(rk), all independent;
θk ∼ IG(t1k, t2k), θ1 < . . . < θK ;
ηk ∼ G(e1k, e2k), all independent; (7)
(µ, σ2) ∼ NIG(m, v, s1, s2), µ > θK ;
(ρi|β) = Φ(β0 + β1di);
β = (β0, β1)
′ ∼ N2(µ0,Σ0).
In the specifications above, Dir, IG, G, NIG and N2 refer to the Dirichlet, inverse gamma, gamma, normal-
inverse-gamma and bivariate normal distributions, respectively. Assume the following parametrisation: shape
t1k and scale t2k in the inverse gamma prior for θk, and mean e1k and shape e2k in the gamma prior for
ηk. Additional notation: Z = {Zi, i = 1, . . . , n}, W = {Wi, i = 1, . . . , n}, θ = {θk, k = 1, . . . ,K} and
η = {ηk, k = 1, . . . ,K}.
The Markov dependence of the probes is expressed in terms of the mixture component indicator variable
Zi. The existence of this dependence is stochastically explained by the distance between the probes through
the probit regression for the Wi variables. Vector q0 could be defined as the stationary distribution of the
Markov chain with transition matrix Q. However, we do not make this restriction in the model as it would
make the inference methodology much harder (more specifically, the sampling step of the qk’s).
The normal component of the mixture is expected to accommodate the expressions of locations that are
likely to form the overexpressed regions we are interested in detecting. The symmetry of this distribution
is believed to help in the detection. Furthermore, since the clusters of interest are definitely a minority of
the probes, we can use this information to elicit informative prior distributions. For example, a prior that
concentrates the probabilities {q0,K+1, q1,K+1, . . . , qK,K+1} around small values. The detection procedure
should be performed based on posterior statistics of the Zi’s. We propose a possible approach in Section 4.2.
4 Bayesian inference
Under the Bayesian paradigm, our aim is to obtain the posterior distribution of all unknown quantities
involved in the model defined in the previous section. Given the high dimensionality and complexity of this
posterior, we devise an MCMC algorithm to sample from it and then use Monte Carlo methods to perform
estimation based on this sample.
4.1 The MCMC algorithm
The proposed MCMC is a Gibbs sampling with some Metropolis-Hastings (MH) steps. The blocking and
sampling schemes are chosen in a way to favor fast convergence of the chain. In this direction, we introduce
a set of independent auxiliary variables V := {Vi, i = 2, . . . , n} which allows direct sampling from the full
conditional distribution of β (see Albert, 1992). Let ~di = (1, di)
′, we set
(Vi|β) ∼ N(β′~di, 1) and Wi =
{
1, if Vi > 0
0, if Vi ≤ 0.
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Note that the original model for X is preserved – simply integrate V out to check it.
Let ψ := {θ, µ, σ2}, we choose the following blocking scheme for the Gibbs sampler:
(Z,W ) ; V ; (q0, Q, β, ψ) ; η.
This scheme leads to a non-irreducible Markov chain which, in turn, does not converge. We circumvent
this problem by making the algorithm a collapsed Gibbs sampling where V is integrated out from the full
conditional distribution of (Z,W ). This strategy makes the chain irreducible and guarantees its convergence
to the target distribution (see Liu, 1994).
All the full conditional densities from the Gibbs sampler are proportional to the joint density of X and
all the unknown quantities of the model – this density is given in (B.1), in Appendix B. We now describe
each step of the algorithm.
Sampling V
The full conditional distribution of V is such that the Vi’s are all independent with distribution N(β
′~di, 1),
truncated to be positive if Wi = 1 and non-positive if Wi = 0.
Sampling (q0, Q, β, ψ)
The four components of this block – q0, Q, β and ψ, are conditionally independent. This means that a
draw from this block is obtained by sampling each of the four components individually from their respective
marginal full conditional distribution. The marginals of the first three components are given in (B.2)-(B.4),
in Appendix B.
The marginal full conditional distribution of ψ is a truncation of a tractable and easy to simulate distribu-
tion, which is defined in (B.5). The truncation region is defined by the restriction {θ1 < θ2 < . . . < θK < µ}.
We sample exactly from this truncated distribution via rejection sampling by proposing from its non-
truncated version and accepting if the restriction is satisfied. Since K is chosen to be small, this algorithm
is computationally efficient.
Sampling η
The ηk’s are sampled (jointly or individually) via Gaussian random walk MH step(s) properly tuned
to have reasonable acceptance rates (see Roberts et al., 1997). Details on the proposal distribution and
acceptance probability of the MH step where each ηk is sampled separately are given in (B.6) and (B.7),
respectively, in Appendix B.
Sampling (Z,W )
This is the most challenging step of the MCMC. Although the full conditional can be factorised into multi-
nomial distributions, obtaining such factorization and the parameters of each multinomial is not straightfor-
ward. Firstly, note that integrating out V provides the following full conditional kernel:
pi(Z,W |·) ∝
n∏
i=1
[
K+1∏
k=1
[
(fk(Xi|ψ)q0k)Zik
]1−Wi [
(fk(Xi|ψ)qk(i−1)k)Zik
]Wi]
× (Φ+i )Wi (Φ−i )1−Wi K+1∏
k=1
qZ0k0k , (8)
with Φ+i = Φ(β
′~di) and Φ−i = Φ(−β′~di).
Direct sampling from (8) is only possible if we adopt the following factorization:
pi(Z,W |·) ∝ pi(Z1|·)
n∏
i=2
pi(Zi|Wi, Zi−1, ·)pi(Wi|Zi−1, ·),
which means that (Z,W ) is sampled in the following order: Z1,W2, Z2, . . . ,Wn, Zn, i.e. forward in time. Each
marginal distribution is multinomial (Bernoulli for the Wi’s) for which the parameter values are obtained
recursively and backward in time. Therefore, we denote this sampling scheme as a backward-filtering-
forward-sampling (BFFS). Details on this sampling step are given in Appendix B.
The MCMC algorithm described here was implemented using the R programming language (R Core Team,
2016).
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4.2 Cluster detection
As it was mentioned before in Section 3, the clusters of interest are expected to be accommodated by the
Gaussian component of the mixture. In this sense, the cluster detection should be performed based on the
posterior probability of one or more probes belonging to the Gaussian component of the mixture. Given
a (approximate) sample of size M from the posterior distribution of Z and a sequence {i1, i2, . . . , iS} of
expressions (S = 1, 2, . . .), the posterior probability of this sequence being a cluster of interest is given by:
1
M
M∑
m=1
S∏
s=1
1(Z
(m)
is,K+1
= 1), (9)
where 1(.) is an indicator function.
A practical (computationally efficient) procedure for cluster detection is to evaluate the probability in
(9) for each individual probe and look for sequences of probes of a minimum size (say 4 or 5) for which
the individual probabilities are high (say > 0.5). For such sequences, the posterior probability in (9) will
be considerably high (given the Markov dependence imposed by the model). One may also be interested in
evaluating this probability for particular sequences – given some practical reason. In Section 5, we search
for a sequence (size 5) of high individual posterior probabilities and report its corresponding joint posterior
probability for each cancer data set.
5 Results for the cancer data sets
We consider five different sets of microarray data representing three types of cancer (see Section 2); the
number of samples varies from 59 to 286 arrays. Since the expression scale is the same for every chromosome,
we perform a joint analysis of all the 24 chromosomes (for each of the five data sets). Moreover, given that
there is no reason to believe that there exists a dependence between the last and first probes of consecutive
chromosomes (there is no distance to be measured), we fix the Wi corresponding to the first probe of each
chromosome to be 0. An important implication of this is that the BFFS step to sample (Z,W ) may be
performed separately for each chromosome, given its conditional independence property. This leads to a
significant improvement in the computational cost.
An important decision to fit the model is to choose the number K of gamma components in the mixture
distribution. The histogram in Figure 1 (a) clearly indicates that a single gamma distribution would not
be appropriate for this analysis due to the multimodal and asymmetric shape of the graph. In order to
investigate other reasonable possibilities, we fit the model with K = 2, 3, 4 and 5 to the “Breast 1” data
set (the distributions of the expressions have similar behavior for all data sets). Results are reported in
Appendix D and indicate that K = 4 is the best choice. The model with K = 2 led to a wide (high variance)
Gaussian component including too many expressions (some of them very low). Results for K = 3 are similar
but still significantly different from those with K = 4 which, in turn, are virtually the same as for K = 5
(especially in terms of overexpressed region detection).
In terms of prior specification, consider again the notation in (7). We assume r0 = (750, 750, 750, 750, 10)
′
as the parameter vector of the Dirichlet prior for q0; here, we indicate that an expression at a location without
a Markov dependence most likely belongs to a gamma component in the mixture. The large equal weights for
the gammas are required in this application involving thousands of locations; small concentration parameters
would lead to a weakly informative prior dominated by the data. This strategy is also considered for the
prior specification of qk. We assume the following matrix:
r =

969.70 484.85 96.97 48.48 10.0
484.85 969.70 484.85 96.97 10.0
96.97 484.85 969.70 484.85 10.0
48.48 96.97 484.85 969.70 10.0
48.48 48.48 96.97 484.85 969.7
 .
The actual values of the hyperparameters for q0 and Q are established in a way that the prior had the same
weight for the Gaussian component and the same level of information for each specification of K in the above
mentioned sensitivity analysis (rounded numbers were fixed for K = 3). The k-th row of matrix r is the
parameter vector of the Dirichlet prior for qk; recall that here we account for the Markov dependence. Note
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that the largest weights were defined in the main diagonal to favor the model to allocate the i-th observation
in the same component of its neighbour from location i − 1. This matrix also has weights decreasing as
we move away from the main diagonal elements – this configuration is used to discourage the model to
assign two consecutive observations in distant components. Another important aspect of this prior are the
small weights specified for the Gaussian component in the last column of the first four rows and the high
weight specified in the last row; this choice is an strategy to make this component accessible only to those
observations having great evidence of overexpression and having neighbours with the same characteristics.
The bivariate normal distribution for the coefficients (β0, β1) is set with mean (4,−8) and covariance
matrix 10 I2; i.e., we assume prior independence for these coefficients and the mean indicates the following
information about the probability of having a Markov dependence: limdi→0 ρi ≈ 1, limdi→1 ρi ≈ 0 and
ρi = 0.5 for di = 0.5.
In this application, we assume a gamma prior distribution with mean 50 and shape 1 for the shape
parameter ηk of all the four gamma components in the mixture; its variance is 50
2. In addition, the mean
θk has the following inverse gamma prior specification: t1k = 4 (for k = 1, 2, 3, 4), t21 = 9, t22 = 18, t23 = 27
and t24 = 36. These hyperparameter choices provide the expected values (3, 6, 9, 12) and the standard
deviations (2.12, 4.24, 6.36, 8.48) for k = 1, 2, 3, 4, respectively. We have chosen the expected values based
on the scale of the observations and the role we expect the gamma components to play in the model. Finally,
we specify a normal-inverse-gamma prior with parameters (15, 25, 2.1, 1.1) for the pair (µ, σ2) related to
the Gaussian component. This implies that E(σ2) = 1 and Var(σ2) = 10. A prior sensitivity analysis was
performed by doubling the standard deviations of (µ, σ2, θ1, . . . , θ4) and the very same results were obtained
– see Appendix D.
Table 1: Posterior mean and standard deviation (in parentheses) for the parameters of the mixture distribution with four gamma
and one Gaussian components.
Breast 1 Breast 2 Breast 3 Ovarian Brain
θ1 4.020 (0.008) 3.769 (0.010) 4.127 (0.008) 3.642 (0.007) 4.365 (0.007)
η1 105.775 (2.920) 112.609 (4.107) 120.475 (3.386) 177.937 (5.546) 268.408 ( 8.919)
θ2 6.398 (0.028) 5.789 (0.051) 6.351 (0.029) 4.991 (0.029) 5.612 (0.032)
η2 20.815 (0.326) 22.487 (0.573) 22.724 (0.399) 36.937 (0.995) 52.620 (1.721)
θ3 8.066 (0.021) 7.684 (0.021) 8.080 (0.023) 7.213 (0.025) 7.776 (0.030)
η3 62.996 (1.596) 65.062 (1.500) 57.345 (1.556) 51.707 (1.238) 61.648 (1.546)
θ4 9.824 (0.028) 9.473 (0.033) 9.882 (0.027) 8.846 (0.029) 9.573 (0.031)
η4 94.436 (2.528) 87.524 (2.750) 93.658 (2.547) 68.373 (1.982) 88.486 (2.623)
µ 12.132 (0.033) 11.997 (0.036) 12.261 (0.032) 11.504 (0.034) 11.780 (0.034)
σ2 0.831 (0.034) 0.947 (0.040) 0.843 (0.033) 1.103 (0.039) 0.873 (0.033)
Table 2: Posterior mean of the coordinates of the Zi’s – posterior weights of the mixture components.
k Breast 1 Breast 2 Breast 3 Ovarian Brain
1 0.138 0.150 0.140 0.120 0.124
2 0.387 0.378 0.381 0.278 0.269
3 0.274 0.286 0.280 0.371 0.365
4 0.165 0.148 0.162 0.188 0.198
5 0.036 0.037 0.037 0.042 0.045
Table 3: Comparison involving pairs of data sets. Number of probes identified in the Gaussian component in both data sets
of the pair, relative to the number of probes identified in the Gaussian component in at least one of the data sets of the pair.
Breast 1 Breast 2 Breast 3 Ovarian Brain
Breast 1 100% 79.1% 87.4% 71.6% 62.9%
Breast 2 100% 84.6% 76.1% 64.5%
Breast 3 100% 75.4% 65.9%
Ovarian 100% 69.3%
Brain 100%
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The MCMC is set to perform 15,000 iterations with a burn-in of 5,000. Let 1(l1×l2) be a l1 × l2 matrix
of ones; in terms of initial values, we consider q
(0)
0 = 0.2 1(5×1) and Q
(0) = 0.2 1(5×5). In addition, we set
β
(0)
0 = 4, β
(0)
1 = −8 as specified in their prior distribution. The initial values of the remaining parameters
are set based on statistics of the data; we break the support of the histogram (see Figure 1) into 4 contiguous
intervals and then evaluate their means and variances to determine: θ
(0)
1 = 4.43, θ
(0)
2 = 6.70, θ
(0)
3 = 8.96,
θ
(0)
4 = 11.23, µ
(0) = 13.50, η
(0)
1 = 50.87, η
(0)
2 = 108.30, η
(0)
3 = 200.30, η
(0)
4 = 330.93 and (σ
2)(0) = 0.21.
The variances of the random walk proposals in the MH step to sample η1, η2, η3 and η4 were chosen to
provide reasonable (around 44%) acceptance rates. Convergence is rapidly attained – Appendix E shows
some diagnostics.
Figure 3: Histogram of all expressions overlaid by the estimated mixture density (black curve) and its components (gammas in blue,
green, yellow and orange, normal in red).
Figure 4: Expression values along chromosome 4. The red dots indicate observations where the Gaussian component has posterior
probability above 0.5.
Table 1 presents the posterior estimates for each component of the mixture distribution and Table 2
their corresponding posterior weight (posterior mean of the coordinates of the Zi’s). For each parameter,
note that the means and standard deviations are similar across the data sets; this suggests mixture densities
having nearly the same shape when comparing different cancers.
Figure 3 shows the histogram of the data overlaid by the estimated mixture density and their components
for each data set. Note that the range of the Gaussian is not too wide and, therefore, accommodates the
expressions in the right tail of the histograms. This result suggests that the mixture with K = 4 gamma
components represents well the data.
Figure 4 shows the behaviour of the expression values along chromosome 4 for all five data sets; here,
we explore a single chromosome since the graph displaying all of them would be difficult to visualise. As
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can be seen, the red dots, representing observations with high posterior probability (> 0.5) of belonging to
the Gaussian component, are concentrated on the top of the graphs. Note that non-Gaussian observations
(black dots) can be identified among Gaussian ones, which indicates high expressions originated from the
right tail of a gamma distribution in the mixture. This occurs as a result of the model structure accounting
for distances between locations to determine the strength of the Markov dependence. Again, the simple
strategy of choosing a threshold above which all points are in red would inflate the number of overexpressed
regions.
We also compute the posterior probability of a specific cluster of 5 locations being an overexpressed region
for each data set – see (9). We evaluate the sequence composed by locations 33,312 to 33,316. Its posterior
probability of being an overexpressed cluster is: 0.9996 (Breast 1), 0.9998 (Breast 2), 0.9998 (Breast 3),
0.9998 (Ovarian) and 0.9989 (Brain).
Another interesting aspect displayed in Figure 4 is the fact that for the same location the expressions from
each data set are similar, consequently, the cluster identification tends also to be similar comparing these
data sets. If we consider all 24 chromosomes (91,090 locations identified via BLAT), the number of probes in
the Gaussian component are: 3,132 (Breast 1), 3,277 (Breast 2), 3,271 (Breast 3), 3,723 (Ovarian) and 3,860
(Brain). Table 3 compares each pair of data sets and indicates the frequency of locations identified in the
Gaussian component in both data sets, relative to the total number of locations identified in the Gaussian
component in at least one of them. Note that the largest percentages (79.1%–87.4%) are obtained for pairs
involving two breast cancer data sets; this is a plausible result suggesting that the model is working well in
this cluster identification problem involving 91,090 locations. The overexpressed regions in the breast cancer
data sets seem to have higher similarity with the ovarian cancer (71.6%–76.1%) than with the brain cancer
(62.9%–69.3%).
(a) (b)
Figure 5: Heat map image indicating for each location the posterior probability of belonging to the Gaussian component. Panel (a)
represents all chromosomes and Panel (b) shows chromosome 1.
(a) (b)
Figure 6: Panel (a): Histogram of the distances between the location of a cluster, with a single observation, and its nearest non-
Gaussian neighbours. Panel (b): Estimated relationship between the distances and ρi (probability of having a Markov dependence with
the previous probe); here, we consider the “Breast 1” data set and the posterior mean of β0 (5.05) and β1 (-9.55) to draw the curve.
Figure 5 shows a grey scale heat map investigating the posterior probabilities of being a Gaussian com-
ponent observation. The results for all 24 chromosomes are shown in panel (a) and only the chromosome
1 is explored in panel (b); images for the chromosomes 2-22, X and Y have a similar behaviour and are
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presented (individually) in Appendix C. The conclusions here reinforce the previous analysis of Figure 4 and
Table 3; i.e., the data sets tend to agree, exhibiting similar probabilities for the same location. Note that a
coherent pattern of grey/black probabilities can be clearly seen in both panels and the majority of locations
are in white due to a estimated probability of Gaussian classification near 0 for most chromosomal regions.
This coherence between results from different microarray data sets, specially between those three for breast
cancer, is a strong evidence that the proposed model is performing well. A disagreement between data sets
for the same type of tumor is not expected and, assuming that the data were correctly preprocessed and
aligned, this would suggest a critical model issue; this is not the case here.
In this application, we have observed different sizes of sequences of consecutive locations belonging to the
Gaussian component when adopting the classification rule described in the caption of Figure 4. The shortest
case is a single observation surrounded by two non-Gaussian neighbours; the longest sequence, comparing all
data sets, involves 17 locations. One may consider that the identification of a single Gaussian location with
non-Gaussian neighbours is potentially a model issue; however, the histogram in Figure 6 (a) shows that
this is not the case. It shows that the distribution of all distances between a single Gaussian location and its
non-Gaussian neighbours is highly concentrated in the region above 0.5. Therefore, the magnitude of these
isolated expressions is compatible with an overexpressed cluster and the model cannot use the neighbourhood
information to change this classification because the neighbours are too far away. These locations belong to
potential clusters but a confirmation relies on their non-observed neighbours.
Figure 6 (b) presents the estimated relationship between the distances and the probability ρi of having
a Markov dependence at location i for the “Breast 1” data; two dashed lines were included to highlight the
probability and the distance 0.5. The posterior means of (β0,β1) for each data set are: (5.05,-9.55) in “Breast
1”, (5.02,-9.50) in “Breast 2”, (5.26,-9.85) in “Breast 3”, (5.27,-9.83) in “Ovarian” and (4.92,-9.31) in the
“Brain” data set. These are all similar, which implies that their corresponding curves will be very close to
the one in panel (b). We can evaluate the decreasing behaviour of the curve to understand the impact of the
distances on ρi; for example, the slow decay before the distance 0.4 indicates that the Markov dependence
is strong for those distances. In addition, the curve has a fast decay between distances 0.4 and 0.6, and is
approximately 0 from 0.8 onwards.
6 Conclusions
In this paper, we have developed a hidden Markov model designed for an application involving Affymetrix
DNA microarray data. The study focuses on the identification of chromosomal regions associated with high
gene expression measurements, which we call overexpressed regions. The microarray probe expressions are
mapped to locations in the human chromosomes using the alignment algorithm BLAT. As a result, the data
is configured as an irregularly spaced sequence along the chromosomes; five different data sets representing
breast, ovarian and brain cancers were considered in the analysis. The original light intensities from the
arrays were preprocessed via RMA.
The proposed model assumes a mixture distribution with four gamma and one normal components to
cluster the observations. The largest mean is imposed for the Gaussian component, which is supposed to
accommodate the target overexpressed values. The model takes advantage of the distances between the
identified locations to determine whether there is a Markov dependence between neighbours and uses such
dependence to (stochastically) define the target clusters. Inference is performed under the Bayesian paradigm
via an MCMC algorithm consisting of a carefully devised Gibbs sampling.
The results indicate that the model is selective in the cluster determination, being able to discriminate well
the locations to identify the overexpressed regions; on average, only 3.8% of the locations are classified (for a
suitable classification rule) in potential overexpressed clusters. Looking at the intersection of overexpressed
regions from the analised data sets and evaluating the coherence pattern exhibited in image graphs, our
findings suggest great similarity between them. As expected, the greatest similarity is observed among the
breast cancer data sets, which is a strong indication that the model is performing well. The real application
also shows that the breast cancer data is more similar to the ovarian cancer than to the brain cancer.
We perform a general cluster identification analysis to present a global picture of the overexpressed
regions across the human genome. This means that the results obtained here can be used for a more
detailed description of specific regions of interest in any chromosome; for example, one can easily compute
12
the probability of a particular set of probes being an overexpressed cluster through the cluster detection
procedure presented in (9).
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Appendix A: Details about BLAT and RMA
The BLAT algorithm was developed to quickly find genome positions having at least 95% similarity with
sequences of interest in a database. In fact, BLAT is available for different types of query sequences and, in
our application, we use this algorithm on DNA to search for chromosome locations having high compatibility
with the 25-bases probe sequences from the microarray. The shorter is the length of the sequence, the higher
is the risk of incorrect mapping; this issue is not peculiar to BLAT and it can also occur in other alignment
techniques. However, as indicated in Allen et al. (2011), BLAT is a popular algorithm being used in several
researches to align probe sequences to a recent release of the human genome or transcriptome. The main
advantage of the method is its low computational cost; BLAT does not keep the whole genome information
in memory allowing high performance in an ordinary Linux computer. In addition, BLAT can be accessed
for small searches through a web server at https://genome.ucsc.edu/cgi-bin/hgBlat. The sources and executables
to install and run large mapping jobs in a computer are freely available for academic, personal and nonprofit
purposes; see http://www.kentinformatics.com for details.
The results obtained via BLAT may contain some inconsistencies; a probe may be aligned to multiple
locations and a location may be associated with two or more probes. We have no additional information to
correct this mapping problem, which affects very few probes and locations; therefore, the involved expression
values will be removed from the study without compromising the analysis.
In the data preprocessing routine, the intensity values are transformed using the standard log2-base scale
and these measurements are adjusted within each chip and across the replicate arrays. Different sources can
cause distortions in the data, for example, cross-hybridization, dust, chip defect, the amount of RNA in the
samples, camera exposure time, scanner calibration, etc. The first three sources affect observations within a
single chip and the remaining ones introduce noise between chips.
Among the different techniques to preprocess the data, we consider the Robust Multi-chip Average
(RMA) (see Irizarry et al., 2003). It has three main steps: background correction, quantile normalization
and summarization. In short, the first step fits a linear model “signal plus error” to explain the intensity of
probe i in the array j; here, the main goal is to estimate the signal component. The quantile normalization
step adjusts the probe intensities to ensure that measurements from different arrays are comparable. Finally,
the summarization step calculates a single value representing the expressions of the probes in each probe set.
In our study, we apply only the first two RMA preprocessing steps. The third step is ignored because
BLAT aligns the probe level data and not the probe set summarised measurement. In order to apply the RMA
background correction and quantile normalization, we use the software R (R Core Team, 2016) and its package
affy (Gautier et al., 2004) integrated into the collaborative project Bioconductor (http://www.bioconductor.org)
providing tools for computational biology (Gentleman et al., 2004). We also highlight the fact that both
RMA and BLAT work only with PM probes; therefore, the MM probes are not considered in our final aligned
data.
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Appendix B: Joint and full conditional distributions
The joint density of X and all the unknown quantities of the model is given by:
pi(X,Z,W, V, q0, Q, ψ, β) =
=
[
n∏
i=1
pi(Xi|Zi, ψ)pi(Zi|Zi−1,Wi, q0, Q)pi(Wi|Vi)pi(Vi|β)
]
pi(q0, Q, ψ, β)
=
[
n∏
i=1
[
K+1∏
k=1
fk(Xi|ψ)Zi,k (qZi,k0k )1−Wi(q
Zi,k
k(i−1)k)
Wi
]
× [1(Wi = 1) 1(Vi > 0) + 1(Wi = 0) 1(Vi ≤ 0)]
× φ(Vi − β′ ~di)
][
K+1∏
k=1
q
Z0,k
0k q
r0k−1
0k
] K+1∏
k1=1
K+1∏
k=1
q
rk1k−1
k1k
 pi(ψ) pi(β), (B.1)
where k(i−1) = j if Zi−1,j = 1, pi(β) = |Σ0|−1/2φ2[Σ−1/20 (β − µ0)] and
pi(ψ) =
[
K∏
k=1
piIG(θk; t1k, t2k) 1(θ1 < . . . < θK) piG(ηk; e1k, e2k)
]
×
[
piNG(µ, σ
2;m, v, s1, s2) 1(µ > max
1≤k≤K
{θk})
]
.
The full conditional distribution of (q0, Q, ψ, β) is:
(q0|·) ∼ Dir
[
r0 +
n∑
i=1
Zi(1−Wi)
]
; (B.2)
(qk|·) ∼ Dir
[
rk +
n∑
i=2
(Zi−1,kWi)Zi
]
; (B.3)
(β|·) ∼ N2(µ∗0,Σ∗0), (B.4)
with Σ∗0 =
(
Σ−10 +
∑n
i=1
~di~di
′)−1
and µ∗0 = Σ
∗
0
(
Σ−10 µ0 +
∑n
i=1 Vi
~di
)
.
(σ2|·) ∼ IG(s∗1, s∗2); (µ|·) ∼ N(m∗, v∗); (θk|·) ∼ IG(t∗1k, t∗2k), k = 1, . . . ,K; (B.5)
where s∗1 = s1 +
1
2 (
∑n
i=1 Zi,K+1) and
s∗2 = s2 +
1
2
[
m2
v +
∑n
i=1 Zi,K+1X
2
i − v1+v∑ni=1 Zi,K+1
(
m
v +
∑n
i=1 Zi,K+1Xi
)2]
;
v∗ = vσ
2
1+v
∑n
i=1 Zi,K+1
and m∗ = v∗
(
m+v
∑n
i=1 Zi,K+1Xi
vσ2
)
;
t∗1k = t1k + ηk
∑n
i=1 Zi,k and t
∗
2k = t2k + ηk
∑n
i=1 Zi,kXi.
The MH algorithm to sample ηk takes into account:
• Proposal distribution:
η∗k ∼ N(ηk, τ2), where ηk is the current value of the chain. (B.6)
• Acceptance probability:
min
{
1 ,
∏
i; Zi,k=1
fk(Xi|η∗k, θk)pi(η∗k)∏
i; Zi,k=1
fk(Xi|ηk, θk)pi(ηk)
}
; (B.7)
where θk is the current value of parameter θk.
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The sampling step of (Z,W ) is as follows:
Z1 ∼ Mult(1, q∗0);
(Wi|Zi−1,j = 1, ·) ∼ Ber(1, p∗(i,j)), i = 2, . . . , n;
(Zi|Wi = l, Zi−1,j = 1, ·) ∼ Mult(1, q∗(i,j,l)), i = 2, . . . , n
where
q∗0k = c1,kq0k/a1; (B.8)
p∗(i,j) = bi,jΦ
+
i /ci,j ;
q∗(i,j,0)k = ci+1,kfk(Xi|ψ)q0k/ai; q∗(i,j,1)k = ci+1,kfk(Xi|ψ)qj,k/bi,j .
Consider cn+1,j = 1, ∀j, and:
an =
K+1∑
k=1
fk(Xn|ψ)q0k; bn,j =
K+1∑
k=1
fk(Xn|ψ)qj,k; cn,j = bn,jΦ+n + anΦ−n ; (B.9)
ai =
K+1∑
k=1
ci+1,kfk(Xi|ψ)q0k; bi,j =
K+1∑
k=1
ci+1,kfk(Xi|ψ)qj,k; ci,j = bi,jΦ+i + aiΦ−i ,
for i = n− 1, . . . , 2;
a1 =
K+1∑
k=1
c1,kq0k.
In the filtering procedure, the calculations are performed recursively, starting from n and moving backwards.
On each step, we compute the scalar ai and the (K + 1)-vectors bi and ci as indicated in (B.9). Next, we
compute the probabilities in (B.8) to update the auxiliary variables Zi and Wi.
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Appendix C: Additional results of the real data application
Chromosome 2 Chromosome 3
Chromosome 4 Chromosome 5
Chromosome 6 Chromosome 7
Chromosome 8 Chromosome 9
Figure C.1: Heat map image (chromosomes 2-9) indicating for each location the posterior probability of belonging to the Gaussian
component.
16
Chromosome 10 Chromosome 11
Chromosome 12 Chromosome 13
Chromosome 14 Chromosome 15
Chromosome 16 Chromosome 17
Figure C.2: Heat map image (chromosomes 10-17) indicating for each location the posterior probability of belonging to the Gaussian
component.
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Chromosome 18 Chromosome 19
Chromosome 20 Chromosome 21
Chromosome 22 Chromosome X
Chromosome Y
Figure C.3: Heat map image (chromosomes 18-22, X and Y ) indicating for each location the posterior probability of belonging to
the Gaussian component.
Appendix D: Sensitivity analysis
In order to investigate the sensitivity of the results to the choice of K (number of gamma components),
we fit the model under four different specifications: K = 2, 3, 4 and 5. The Dirichlet priors for q0 and
Q are specified in a way that the Gaussian component’s weight and the degree of information in the prior
(sum of the hyperparameters of the Dirichlet) are the same across all configurations. Results are presented
in Figure D.1 and Table D.1. They indicate that K = 2 does not provide good results as the Gaussian
component’s variance is too high to accommodate overexpressed probes. Results are quite similar (but
significantly different) for K = 3 and K = 4, and they are practically the same for K = 4 and K = 5. In
particular, two of the gamma components for K = 5 are virtually the same – the posterior mean of (θ, η)
for each of these components are (7.81, 49.23) and (7.90, 46.89). Hence, we choose the model with K = 4,
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for which results are reported in Section 5.
Figure D.1: Histogram of all expressions (“Breast 1” data) overlaid by the estimated mixture density (black curve) and its components
(gammas in yellow, normal in red), for all the four values of K.
Table D.1: Posterior estimates (for each K, “Breast 1” data) of the weight, µ and σ2 related to the Gaussian component, and
the mean (Expec.) and variance (Var.) of the (normalised) mixture of gammas; standard errors in parentheses.
K weight µ σ2 Expec. Var.
2 0.1715 (0.0033) 10.2320 (0.0281) 2.2208 (0.0362) 6.6956 (0.0103) 2.3649 (0.0177)
3 0.0654 (0.0017) 11.4605 (0.0341) 1.3443 (0.0388) 7.0111 (0.0074) 2.8614 (0.0209)
4 0.0365 (0.0011) 12.1317 (0.0330) 0.8314 (0.0338) 7.1193 (0.0062) 3.2746 (0.0226)
5 0.0383 (0.0012) 12.0889 (0.0354) 0.8599 (0.0354) 7.1112 (0.0060) 3.4991 (0.0204)
Table D.2: Comparison of prior specifications (“Breast 1” data). Posterior estimates of the weight, µ and σ2 related to the Gaussian
component, and the mean (Expec.) and variance (Var.) of the (normalised) mixture of gammas; standard errors in parentheses.
Prior weight µ σ2 Expec. Var.
Original 0.0365 (0.0011) 12.1317 (0.0330) 0.8314 (0.0338) 7.1193 (0.0059) 3.2746 (0.0226)
Vague 0.0364 (0.0011) 12.1338 (0.0333) 0.8305 (0.0334) 7.1197 (0.0059) 3.2736 (0.0223)
We also perform a prior sensitive analysis for the parameters of the mixture components, with K = 4.
We consider two different prior specifications, where the standard deviations from one of them are twice
the standard deviations from the other one. More specifically, we assume in specification 1: (µ, σ2) ∼
NIG(15, 25, 2.1, 1.1), θk ∼ IG(4, t2k) with t2k = 9, 18, 27, 36, for k = 1, 2, 3, 4, respectively; this
assigns means (3, 6, 9, 12) and standard deviations (2.12, 4.24, 6.36, 8.48) for each of the four gamma
components. Note that this configuration is the original one explored in Section 5. In specification 2, we
set: (µ, σ2) ∼ NIG(15, 100, 2.025, 1.025), θk ∼ IG(2.5, t2k) with t2k = 4.5, 9.0, 13.5, 18.0, for k = 1, 2, 3, 4,
respectively; this provides the same means, but larger standard deviations (4.24, 8.48, 12.72, 16.96) for each
of the four gamma components. Results are shown in Figure D.2 and Table D.2. They are visually the same
indicating robustness to the prior specification for these parameters.
Appendix E: MCMC diagnostics
As we have mentioned in the text, the MCMC we design has good convergence properties. This is due to
the chosen blocking scheme and the fact that we can sample directly from the full conditional distribution
of (Z,W ). Figures E.1 and E.2 present some graphs of the MCMC chain for the block (Z,W ) to support
this point. The trace plots show good mixing properties and the ergodic average trajectories show fast
convergence.
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Figure D.2: Histogram of all expressions (“Breast 1” data) overlaid by the estimated mixture density (black curve) and its components
(gammas in yellow, normal in red), for the two prior specifications.
Figure E.1: Trace plots of a pair (Zi5,Wi) with posterior mean around 0.5 (“Breast 1” data).
Figure E.2: Evolution of the ergodic average of three pairs (Zi5,Wi) along the MCMC chain (“Breast 1” data).
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